Evidence map›Paper›PMID 40473926›Full record

ArticleCommunications biology2025

Distinct functional domains of Dystroglycan regulate inhibitory synapse formation and maintenance in cerebellar Purkinje cells.

Jennifer N Jahncke, Eric Schnell, Kevin M Wright

Abstract read
In one paragraph

Article in Communications biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Cytoplasmic region of beta-dystroglycan is essential for postsynaptic maturation and neuromuscular function in mice.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Article
  3. Review
  4. Alpha-neurexins in health and disease.Frontiers in molecular neuroscience · 2025
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Jennifer N JahnckeNeuroscience Graduate Program, Oregon Health & Science University, Portland, OR, USA.ORCID http://orcid.org/0000-0003-2319-6109
Eric SchnellOperative Care Division, Portland VA Health Care System, Portland, OR, USA.
Kevin M WrightVollum Institute, Oregon Health & Science University, Portland, OR, USA. wrighke@ohsu.edu.ORCID http://orcid.org/0000-0001-5094-5270

Funding

Ultrastructure and Single Particle Microscopy CoreP30NS061800 · NINDS · OREGON HEALTH & SCIENCE UNIVERSITY · PI AICHER, SUE A · 2009 to 2020
$6.6M
The role of dystroglycan in neural circuit development.R01NS091027 · NINDS · OREGON HEALTH & SCIENCE UNIVERSITY · PI WRIGHT, KEVIN · 2016 to 2020
$1.9M
Alpha2delta-mediated control of neuronal signalingR01NS126247 · NINDS · OREGON HEALTH & SCIENCE UNIVERSITY · PI Eric Schnell · 2022 to 2026
$1.7M
Synaptic dysfunction in models of dystroglycanopathyR01NS131299 · NINDS · OREGON HEALTH & SCIENCE UNIVERSITY · PI Kevin Wright · 2024 to 2026
$1.4M
Dystroglycan regulates cerebellar synapse functionF31NS120649 · NINDS · OREGON HEALTH & SCIENCE UNIVERSITY · PI JAHNCKE, JENNIFER · 2020 to 2022
$138k
BLRD VA I01 BX004938BLRD VA I01 BX006921Muscular Dystrophy Association (Muscular Dystrophy Association Inc.) NANINDS NIH HHS F31 NS120649NINDS NIH HHS P30 NS061800NINDS NIH HHS R01 NS091027NINDS NIH HHS R01 NS126247NINDS NIH HHS R01 NS131299U.S. Department of Defense (United States Department of Defense) W81XWH-18-1-0598U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS) F31NS120649U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS) R01NS091027U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS) R01NS126247U.S. Department of Veterans Affairs (Department of Veterans Affairs) I01-BX004938
6 · The paper itself

Abstract

Dystroglycan is a cell adhesion molecule that localizes to synapses throughout the nervous system. While Dystroglycan is required to maintain inhibitory synapses from cerebellar molecular layer interneurons (MLIs) onto Purkinje cells (PCs) whether initial synaptogenesis during development is dependent on Dystroglycan has not been examined. We show that mice with conditional deletion of Dystroglycan from Purkinje cells prior to synaptogenesis results in impaired MLI:PC synapse formation and function due to reduced presynaptic inputs and abnormal postsynaptic GABA

Indexed as

DystroglycansPurkinje CellsSynapsesAnimalsCerebellumGlycosylationInterneuronsMiceMice, KnockoutReceptors, GABA-ADystroglycansReceptors, GABA-A

Identifiers

PMID40473926
PMCPMC12141699

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.